771888 |
FRONTIERS IN IMMUNOLOGY |
Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target |
2021-11-19 |
10.3389/fimmu.2021.688930 |
Mackay Graham A., Fernandopulle Nithya A., Ding Jie, McComish Jeremy, Soeding Paul F. |
771887 |
FRONTIERS IN IMMUNOLOGY |
Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8+ and CD4+ Regulatory T Cells in Lupus |
2021-11-19 |
10.3389/fimmu.2021.718359 |
Singh Ram P., Hahn Bevra H., Bischoff David S. |
771886 |
FRONTIERS IN IMMUNOLOGY |
Dynamic Process of Secondary Pulmonary Infection in Mice With Intracerebral Hemorrhage |
2021-11-19 |
10.3389/fimmu.2021.767155 |
Zhang Hanyu, Huang Yingying, Li Xiaojin, Han Xu, Hu Jing, Wang Bin, Zhang Lin, Zhuang Pengwei, Zhang Yanjun |
771885 |
FRONTIERS IN IMMUNOLOGY |
CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab |
2021-11-19 |
10.3389/fimmu.2021.794638 |
Chang Xiao L., Wu Helen L., Webb Gabriela M., Tiwary Meenakshi, Hughes Colette, Reed Jason S., Hwang Joseph, Waytashek Courtney, Boyle Carla, Pessoa Cleiton, Sylwester Andrew W., Morrow David, Belica Karina, Fischer Miranda, Kelly Scott, Pourhassan Nader, Bochart Rachele M., Smedley Jeremy, Recknor Christopher P., Hansen Scott G., Sacha Jonah B. |
771884 |
ONCOLOGY LETTERS |
Zinc‑finger protein 750 mitigates malignant biological behavior of oral CSC‑like cells enriched from parental CAL‑27 cells |
2021-11-19 |
10.3892/ol.2021.13146 |
Xu Cong, Yang Hong-Li, Yang Yi-Kun, Pan Li, Chen Hai-Ying |
771883 |
ONCOLOGY LETTERS |
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib |
2021-11-19 |
10.3892/ol.2021.13143 |
Emile George, Penager Sarah, Levy Christelle, Johnson Alison, Allouache Djelila, Lequesne Justine, Hrab Ioana, Segura Carine, Morel Adeline, Gunzer Katarina, Faveyrial Audrey, Cherifi Francois, Da Silva Angelique |
771882 |
ONCOLOGY LETTERS |
RBM38 is negatively regulated by miR‑320b and enhances Adriamycin resistance in breast cancer cells |
2021-11-19 |
10.3892/ol.2021.13145 |
Ke Jing, Ni Kan, Xue Huimin, Li Jia |
771881 |
ONCOLOGY LETTERS |
MCP‑1 targeting: Shutting off an engine for tumor development (Review) |
2021-11-19 |
10.3892/ol.2021.13144 |
Wang Liang, Lan Jinxin, Tang Jiaping, Luo Na |
771880 |
BIOMEDICINES |
Genetic Determinants of Plasma Low-Density Lipoprotein Cholesterol Levels: Monogenicity, Polygenicity, and “Missing” Heritability |
2021-11-19 |
10.3390/biomedicines9111728 |
Martín-Campos Jesús Maria |
771879 |
BIOMEDICINES |
Clinical and Radiological Deterioration in a Case of Creutzfeldt–Jakob Disease following SARS-CoV-2 Infection: Hints to Accelerated Age-Dependent Neurodegeneration |
2021-11-19 |
10.3390/biomedicines9111730 |
Ciolac Dumitru, Racila Renata, Duarte Carolina, Vasilieva Maria, Manea Diana, Gorincioi Nadejda, Condrea Alexandra, Crivorucica Igor, Zota Eremei, Efremova Daniela, Crivorucica Veaceslav, Ciocanu Mihail, Movila Alexandru, Groppa Stanislav A. |